Loading...

Alexa Fluor® 700 anti-mouse I-A/I-E Antibody Alexa Fluor® 700 anti-mouse I-A/I-E Antibody

Pricing & Availability
Clone
M5/114.15.2 (See other available formats)
Regulatory Status
RUO
Other Names
MHC class II
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_M5slash114_Alx700_020608
C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2)Alexa Fluor® 700 (filled histogram) or rat IgG2b, κ Alexa Fluor® 700 isotype control (open histogram).
  • 1_M5slash114_Alx700_020608
    C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2)Alexa Fluor® 700 (filled histogram) or rat IgG2b, κ Alexa Fluor® 700 isotype control (open histogram).
  • 34_Mouse_Spleen_F480_MHCII
    Confocal image of C57BL/6 mouse spleen sample acquired using the IBEX method of highly multiplexed antibody-based imaging: MHCII (blue) in Cycle 2 and F4/80 (magenta) in Cycle 2. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 39_Mouse_Thymus_CD68_MHCII
    Confocal image of C57BL/6 mouse thymus sample acquired using the IBEX method of highly multiplexed antibody-based imaging: CD68 (cyan) in Cycle 3 and MHCII (red) in Cycle 3. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 45_Mouse_Lung_EpCAM_MHCII_CD169
    Confocal image of C57BL/6 mouse lung sample acquired using the IBEX method of highly multiplexed antibody-based imaging: EpCAM (blue) in Cycle 2, MHCII (magenta) in Cycle 2, and CD169 (green) in Cycle 4. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 51_Mouse_Gut_EpCAM_CD31_MHCII
    Confocal image of C57BL/6 mouse small intestine sample acquired using the IBEX method of highly multiplexed antibody-based imaging: EpCAM (blue) in Cycle 1, CD31 (magenta) in Cycle 2, and MHCII (green) in Cycle 3. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 55_Mouse_Liver_Ecadherin_MHCII
    Confocal image of C57BL/6 mouse liver sample acquired using the IBEX method of highly multiplexed antibody-based imaging: E-Cadherin (blue) in Cycle 1 and MHCII (magenta) in Cycle 4. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
107622 100 µg SEK1806
Check Availability


Need larger quantities of this item?
Request Bulk Quote
107621 25 µg SEK790
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

These class II molecules are expressed on antigen presenting cells (including B cells) and a subset of T cells from H-2b,d,q,r bearing mice and are involved in antigen presentation to T cells expressing CD3/TCR and CD4 proteins.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Activated C57BL/6 mouse spleen cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

SB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

The M5/114.15.2 antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes. Clone M5/114.15.2 however does not react wtih I-Af, I-Ak, or I-As MHC class II alloantigens.1

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of frozen sections2,3,6, in vitro and in vivo blocking of antigen presentation or ligand binding4-7, and spatial biology (IBEX)17,18. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 107655 & 107656).

Additional Product Notes

Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).

Application References
  1. Bhattacharya A, et al. 1981. J. Immunol. 127:2488. (IP)
  2. Viville S, et al. 1993. Cell 72:635. (IHC)
  3. Nelson AJ, et al. 1993. J. Immunol. 151:2453. (IHC)
  4. Shi Y, et al. 1998. J. Exp. Med. 187:367. (Block)
  5. Yamashita I, et al. 1993. Int. Immunol. 5:1139.
  6. Guo M, et al. 1995. Zygote 3:65. (IHC)
  7. Kim A, et al. 2004. Exp. Mol. Med. 36:428. (Block)
  8. Luckashenak NA, et al. 2006. J. Immunol. 177:5177.
  9. Venanzi ES, et al. 2007. J. Immunol. 179:5693.
  10. Christensen SR, et al. 2006. Immunity 25:417. PubMed
  11. Matte-Martone C, et al. 2008. Blood 111:3884. PubMed
  12. De Pascalis R, et al. 2008. Infect. Immun. 76:4311. PubMed
  13. Kuns RD, et al. 2009. Blood 113:5999. PubMed
  14. Sabatino JJ, et al. 2011. J. Exp. Med. 208:81. PubMed
  15. Draber P, et al. 2011. Mol Cell Biol. 22:4550. PubMed
  16. Fu H, et al. 2014. Nat Commun. 5:3436. PubMed
  17. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  18. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  2. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  3. Mathur R, et al. 2019. Mucosal Immunol. 12:612. PubMed
  4. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  5. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  6. Mancini M, et al. 2021. Sci Rep. 11:21171. PubMed
  7. Kuczynski EA, et al. 2022. EMBO Mol Med. 14:e15816. PubMed
  8. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  9. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  10. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  11. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  12. Cousin N, et al. 2022. Cells. 12: . PubMed
  13. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  14. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  15. Jameson VJ, et al. 2022. Cytometry A. 101:922. PubMed
  16. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  17. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  18. Bonifacio JPPL, et al. 2022. J Virol. 96:e0087122. PubMed
  19. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  20. Tang Y, et al. 2023. Clin Transl Med. 13:e1237. PubMed
  21. Solier S, et al. 2023. Nature. 617:386. PubMed
  22. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  23. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  24. Zhang R, et al. 2019. Cell Rep. 28:2647. PubMed
  25. Mancini M, et al. 2019. J Immunol. 202:1479. PubMed
  26. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  27. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  28. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  29. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  30. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  31. Dong L, et al. 2021. Cancer Cell. . PubMed
  32. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  33. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  34. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  35. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  36. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  37. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  38. Dupont C, et al. 2015. J Immunol. 195: 4369 - 4377. PubMed
  39. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  40. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  41. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  42. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  43. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  44. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  45. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  46. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  47. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  48. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  49. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  50. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  51. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  52. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  53. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  54. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  55. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  56. Ortiz-Bonilla CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  57. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
  58. Dupont C, et al. 2014. PLoS Pathog. 10:1004047. PubMed
  59. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  60. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  61. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  62. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  63. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  64. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  65. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  66. Chen YG, et al. 2020. Molecular Cell. 76(1):96-109. PubMed
  67. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  68. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  69. Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
  70. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  71. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  72. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  73. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  74. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  75. De Simone G, et al. 2021. Immunity. :. PubMed
  76. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  77. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  78. Blriot C, et al. 2021. Immunity. :. PubMed
  79. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  80. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  81. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  82. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  83. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  84. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  85. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  86. Quiding-Järbrink M, et al. 2010. PLoS One. 5:e15018. PubMed
  87. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  88. Cunha LD et al. 2018. Cell. 175(2):429-441 . PubMed
  89. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  90. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  91. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  92. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  93. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  94. Utz SG, et al. 2020. Cell. 181(3):557-573. PubMed
  95. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  96. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  97. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  98. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  99. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  100. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  101. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  102. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  103. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  104. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  105. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  106. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  107. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  108. Mogilenko DA et al. 2019. Cell. 177(5):1201-1216 . PubMed
  109. Braza MS et al. 2018. Immunity. 49(5):819-828 . PubMed
  110. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  111. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  112. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  113. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  114. Droho S, et al. 2020. J Vis Exp. . PubMed
  115. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  116. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  117. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  118. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  119. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  120. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  121. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  122. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  123. C Khouili S, et al. 2020. Cell Rep. 33:108468. PubMed
  124. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  125. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  126. Mathur R, et al. 2019. Mucosal Immunol. 12:612. PubMed
  127. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  128. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  129. Mancini M, et al. 2021. Sci Rep. 11:21171. PubMed
  130. Kuczynski EA, et al. 2022. EMBO Mol Med. 14:e15816. PubMed
  131. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  132. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  133. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  134. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  135. Cousin N, et al. 2022. Cells. 12: . PubMed
  136. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  137. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  138. Jameson VJ, et al. 2022. Cytometry A. 101:922. PubMed
  139. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  140. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  141. Bonifacio JPPL, et al. 2022. J Virol. 96:e0087122. PubMed
  142. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  143. Tang Y, et al. 2023. Clin Transl Med. 13:e1237. PubMed
  144. Solier S, et al. 2023. Nature. 617:386. PubMed
  145. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  146. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  147. Zhang R, et al. 2019. Cell Rep. 28:2647. PubMed
  148. Mancini M, et al. 2019. J Immunol. 202:1479. PubMed
  149. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  150. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  151. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  152. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  153. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  154. Dong L, et al. 2021. Cancer Cell. . PubMed
  155. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  156. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  157. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  158. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  159. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  160. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  161. Dupont C, et al. 2015. J Immunol. 195: 4369 - 4377. PubMed
  162. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  163. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  164. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  165. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  166. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  167. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  168. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  169. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  170. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  171. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  172. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  173. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  174. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  175. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  176. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  177. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  178. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  179. Ortiz-Bonilla CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  180. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
  181. Dupont C, et al. 2014. PLoS Pathog. 10:1004047. PubMed
  182. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  183. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  184. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  185. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  186. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  187. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  188. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  189. Chen YG, et al. 2020. Molecular Cell. 76(1):96-109. PubMed
  190. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  191. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  192. Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
  193. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  194. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  195. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  196. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  197. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  198. De Simone G, et al. 2021. Immunity. :. PubMed
  199. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  200. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  201. Blriot C, et al. 2021. Immunity. :. PubMed
  202. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  203. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  204. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  205. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  206. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  207. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  208. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  209. Quiding-Järbrink M, et al. 2010. PLoS One. 5:e15018. PubMed
  210. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  211. Cunha LD et al. 2018. Cell. 175(2):429-441 . PubMed
  212. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  213. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  214. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  215. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  216. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  217. Utz SG, et al. 2020. Cell. 181(3):557-573. PubMed
  218. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  219. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  220. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  221. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  222. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  223. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  224. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  225. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  226. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  227. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  228. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  229. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  230. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  231. Mogilenko DA et al. 2019. Cell. 177(5):1201-1216 . PubMed
  232. Braza MS et al. 2018. Immunity. 49(5):819-828 . PubMed
  233. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  234. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  235. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  236. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  237. Droho S, et al. 2020. J Vis Exp. . PubMed
  238. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  239. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  240. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  241. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  242. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  243. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  244. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  245. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  246. C Khouili S, et al. 2020. Cell Rep. 33:108468. PubMed
RRID
AB_493727 (BioLegend Cat. No. 107622)
AB_493726 (BioLegend Cat. No. 107621)

Antigen Details

Structure
MHC class II
Distribution

B cell and activated T cells, APCs of the H-2b,d,q,r bearing mice

Function
Antigen presentation
Ligand/Receptor
CD3/TCR, CD4
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, T cells, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
MHC Antigens
Antigen References

1. Watts C. 1997. Ann. Rev. Immunol. 15:821.
2. Pamer E, et al. 1998. Ann. Rev. Immunol. 16:323.

Gene ID
14961 View all products for this Gene ID 14969 View all products for this Gene ID
UniProt
View information about I-A/I-E on UniProt.org

Related FAQs

If an antibody clone has been previously successfully used in IBEX in one fluorescent format, will other antibody formats work as well?

It’s likely that other fluorophore conjugates to the same antibody clone will also be compatible with IBEX using the same sample fixation procedure. Ultimately a directly conjugated antibody’s utility in fluorescent imaging and IBEX may be specific to the sample and microscope being used in the experiment. Some antibody clone conjugates may perform better than others due to performance differences in non-specific binding, fluorophore brightness, and other biochemical properties unique to that conjugate.

Will antibodies my lab is already using for fluorescent or chromogenic IHC work in IBEX?

Fundamentally, IBEX as a technique that works much in the same way as single antibody panels or single marker IF/IHC. If you’re already successfully using an antibody clone on a sample of interest, it is likely that clone will have utility in IBEX. It is expected some optimization and testing of different antibody fluorophore conjugates will be required to find a suitable format; however, legacy microscopy techniques like chromogenic IHC on fixed or frozen tissue is an excellent place to start looking for useful antibodies.

Are other fluorophores compatible with IBEX?

Over 18 fluorescent formats have been screened for use in IBEX, however, it is likely that other fluorophores are able to be rapidly bleached in IBEX. If a fluorophore format is already suitable for your imaging platform it can be tested for compatibility in IBEX.

The same antibody works in one tissue type but not another. What is happening?

Differences in tissue properties may impact both the ability of an antibody to bind its target specifically and impact the ability of a specific fluorophore conjugate to overcome the background fluorescent signal in a given tissue. Secondary stains, as well as testing multiple fluorescent conjugates of the same clone, may help to troubleshoot challenging targets or tissues. Using a reference control tissue may also give confidence in the specificity of your staining.

How can I be sure the staining I’m seeing in my tissue is real?

In general, best practices for validating an antibody in traditional chromogenic or fluorescent IHC are applicable to IBEX. Please reference the Nature Methods review on antibody based multiplexed imaging for resources on validating antibodies for IBEX.

Other Formats

View All I-A/I-E Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse I-A/I-E (Maxpar® Ready) M5/114.15.2 FC,CyTOF®
Brilliant Violet 605™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 650™ anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 594 anti-mouse I-A/I-E M5/114.15.2 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 785™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 711™ anti-mouse I-A/I-E M5/114.15.2 FC
APC/Fire™ 750 anti-mouse I-A/I-E M5/114.15.2 FC
TotalSeq™-A0117 anti-mouse I-A/I-E M5/114.15.2 PG
Ultra-LEAF™ Purified anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,IP,Block
TotalSeq™-B0117 anti-mouse I-A/I-E M5/114.15.2 PG
TotalSeq™-C0117 anti-mouse I-A/I-E M5/114.15.2 PG
Spark Blue™ 550 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Fire™ 640 anti-mouse I-A/I-E M5/114.15.2 FC
FITC anti-mouse I-A/I-E M5/114.15.2 FC
Purified anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,IP,Block
PE/Cyanine5 anti-mouse I-A/I-E M5/114.15.2 FC
APC anti-mouse I-A/I-E M5/114.15.2 FC
PE anti-mouse I-A/I-E M5/114.15.2 FC
Biotin anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 488 anti-mouse I-A/I-E M5/114.15.2 FC,3D IHC
Alexa Fluor® 647 anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 700 anti-mouse I-A/I-E M5/114.15.2 FC,SB
Pacific Blue™ anti-mouse I-A/I-E M5/114.15.2 FC
PerCP/Cyanine5.5 anti-mouse I-A/I-E M5/114.15.2 FC
PerCP anti-mouse I-A/I-E M5/114.15.2 FC
APC/Cyanine7 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Cyanine7 anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 510™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 421™ anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,SB
Spark YG™ 581 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Fire™ 810 anti-mouse I-A/I-E M5/114.15.2 FC
Spark UV™ 387 anti-mouse I-A/I-E M5/114.15.2 FC
Spark Violet™ 538 anti-mouse I-A/I-E M5/114.15.2 FC
PerCP/Fire™ 806 anti-mouse I-A/I-E M5/114.15.2 FC
Spark Red™ 718 anti-mouse I-A/I-E M5/114.15.2 FC
APC/Fire™ 810 anti-mouse I-A/I-E M5/114.15.2 FC
Spark PLUS UV395™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 750™ anti-mouse I-A/I-E M5/114.15.2 FC
Spark YG™ 593 anti-mouse I-A/I-E (Flexi-Fluor™) Antibody M5/114.15.2 FC
Spark NIR™ 685 anti-mouse I-A/I-E (Flexi-Fluor™) Antibody M5/114.15.2 FC
StarBright UltraViolet 795 anti-mouse I-A/I-E M5/114.15.2 FC
Spark PLUS B574™ anti-mouse I-A/I-E Antibody M5/114.15.2 FC
Go To Top Version: 6    Revision Date: 04-21-2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
M5/114.15.2 (See other available formats)
Regulatory Status
RUO
Other Names
MHC class II
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_M5slash114_Alx700_020608
C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2)Alexa Fluor® 700 (filled histogram) or rat IgG2b, κ Alexa Fluor® 700 isotype control (open histogram).
  • 1_M5slash114_Alx700_020608
    C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2)Alexa Fluor® 700 (filled histogram) or rat IgG2b, κ Alexa Fluor® 700 isotype control (open histogram).
  • 34_Mouse_Spleen_F480_MHCII
    Confocal image of C57BL/6 mouse spleen sample acquired using the IBEX method of highly multiplexed antibody-based imaging: MHCII (blue) in Cycle 2 and F4/80 (magenta) in Cycle 2. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 39_Mouse_Thymus_CD68_MHCII
    Confocal image of C57BL/6 mouse thymus sample acquired using the IBEX method of highly multiplexed antibody-based imaging: CD68 (cyan) in Cycle 3 and MHCII (red) in Cycle 3. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 45_Mouse_Lung_EpCAM_MHCII_CD169
    Confocal image of C57BL/6 mouse lung sample acquired using the IBEX method of highly multiplexed antibody-based imaging: EpCAM (blue) in Cycle 2, MHCII (magenta) in Cycle 2, and CD169 (green) in Cycle 4. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 51_Mouse_Gut_EpCAM_CD31_MHCII
    Confocal image of C57BL/6 mouse small intestine sample acquired using the IBEX method of highly multiplexed antibody-based imaging: EpCAM (blue) in Cycle 1, CD31 (magenta) in Cycle 2, and MHCII (green) in Cycle 3. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
  • 55_Mouse_Liver_Ecadherin_MHCII
    Confocal image of C57BL/6 mouse liver sample acquired using the IBEX method of highly multiplexed antibody-based imaging: E-Cadherin (blue) in Cycle 1 and MHCII (magenta) in Cycle 4. Tissues were prepared using ~1% (vol/vol) formaldehyde and a detergent. Following fixation, samples are immersed in 30% (wt/vol) sucrose for cryoprotection. Images are courtesy of Drs. Andrea J. Radtke and Ronald N. Germain of the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
107622 100 µg SEK1806
Check Availability


Need larger quantities of this item?
Request Bulk Quote
107621 25 µg SEK790
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

These class II molecules are expressed on antigen presenting cells (including B cells) and a subset of T cells from H-2b,d,q,r bearing mice and are involved in antigen presentation to T cells expressing CD3/TCR and CD4 proteins.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Activated C57BL/6 mouse spleen cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

SB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

The M5/114.15.2 antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes. Clone M5/114.15.2 however does not react wtih I-Af, I-Ak, or I-As MHC class II alloantigens.1

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of frozen sections2,3,6, in vitro and in vivo blocking of antigen presentation or ligand binding4-7, and spatial biology (IBEX)17,18. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 107655 & 107656).

Additional Product Notes

Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).

Application References
  1. Bhattacharya A, et al. 1981. J. Immunol. 127:2488. (IP)
  2. Viville S, et al. 1993. Cell 72:635. (IHC)
  3. Nelson AJ, et al. 1993. J. Immunol. 151:2453. (IHC)
  4. Shi Y, et al. 1998. J. Exp. Med. 187:367. (Block)
  5. Yamashita I, et al. 1993. Int. Immunol. 5:1139.
  6. Guo M, et al. 1995. Zygote 3:65. (IHC)
  7. Kim A, et al. 2004. Exp. Mol. Med. 36:428. (Block)
  8. Luckashenak NA, et al. 2006. J. Immunol. 177:5177.
  9. Venanzi ES, et al. 2007. J. Immunol. 179:5693.
  10. Christensen SR, et al. 2006. Immunity 25:417. PubMed
  11. Matte-Martone C, et al. 2008. Blood 111:3884. PubMed
  12. De Pascalis R, et al. 2008. Infect. Immun. 76:4311. PubMed
  13. Kuns RD, et al. 2009. Blood 113:5999. PubMed
  14. Sabatino JJ, et al. 2011. J. Exp. Med. 208:81. PubMed
  15. Draber P, et al. 2011. Mol Cell Biol. 22:4550. PubMed
  16. Fu H, et al. 2014. Nat Commun. 5:3436. PubMed
  17. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  18. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  2. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  3. Mathur R, et al. 2019. Mucosal Immunol. 12:612. PubMed
  4. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  5. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  6. Mancini M, et al. 2021. Sci Rep. 11:21171. PubMed
  7. Kuczynski EA, et al. 2022. EMBO Mol Med. 14:e15816. PubMed
  8. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  9. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  10. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  11. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  12. Cousin N, et al. 2022. Cells. 12: . PubMed
  13. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  14. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  15. Jameson VJ, et al. 2022. Cytometry A. 101:922. PubMed
  16. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  17. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  18. Bonifacio JPPL, et al. 2022. J Virol. 96:e0087122. PubMed
  19. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  20. Tang Y, et al. 2023. Clin Transl Med. 13:e1237. PubMed
  21. Solier S, et al. 2023. Nature. 617:386. PubMed
  22. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  23. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  24. Zhang R, et al. 2019. Cell Rep. 28:2647. PubMed
  25. Mancini M, et al. 2019. J Immunol. 202:1479. PubMed
  26. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  27. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  28. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  29. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  30. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  31. Dong L, et al. 2021. Cancer Cell. . PubMed
  32. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  33. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  34. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  35. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  36. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  37. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  38. Dupont C, et al. 2015. J Immunol. 195: 4369 - 4377. PubMed
  39. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  40. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  41. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  42. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  43. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  44. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  45. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  46. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  47. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  48. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  49. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  50. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  51. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  52. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  53. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  54. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  55. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  56. Ortiz-Bonilla CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  57. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
  58. Dupont C, et al. 2014. PLoS Pathog. 10:1004047. PubMed
  59. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  60. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  61. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  62. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  63. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  64. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  65. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  66. Chen YG, et al. 2020. Molecular Cell. 76(1):96-109. PubMed
  67. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  68. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  69. Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
  70. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  71. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  72. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  73. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  74. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  75. De Simone G, et al. 2021. Immunity. :. PubMed
  76. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  77. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  78. Blriot C, et al. 2021. Immunity. :. PubMed
  79. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  80. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  81. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  82. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  83. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  84. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  85. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  86. Quiding-Järbrink M, et al. 2010. PLoS One. 5:e15018. PubMed
  87. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  88. Cunha LD et al. 2018. Cell. 175(2):429-441 . PubMed
  89. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  90. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  91. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  92. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  93. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  94. Utz SG, et al. 2020. Cell. 181(3):557-573. PubMed
  95. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  96. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  97. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  98. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  99. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  100. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  101. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  102. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  103. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  104. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  105. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  106. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  107. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  108. Mogilenko DA et al. 2019. Cell. 177(5):1201-1216 . PubMed
  109. Braza MS et al. 2018. Immunity. 49(5):819-828 . PubMed
  110. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  111. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  112. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  113. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  114. Droho S, et al. 2020. J Vis Exp. . PubMed
  115. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  116. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  117. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  118. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  119. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  120. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  121. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  122. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  123. C Khouili S, et al. 2020. Cell Rep. 33:108468. PubMed
  124. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  125. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  126. Mathur R, et al. 2019. Mucosal Immunol. 12:612. PubMed
  127. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  128. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  129. Mancini M, et al. 2021. Sci Rep. 11:21171. PubMed
  130. Kuczynski EA, et al. 2022. EMBO Mol Med. 14:e15816. PubMed
  131. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  132. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  133. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  134. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  135. Cousin N, et al. 2022. Cells. 12: . PubMed
  136. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  137. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  138. Jameson VJ, et al. 2022. Cytometry A. 101:922. PubMed
  139. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  140. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  141. Bonifacio JPPL, et al. 2022. J Virol. 96:e0087122. PubMed
  142. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  143. Tang Y, et al. 2023. Clin Transl Med. 13:e1237. PubMed
  144. Solier S, et al. 2023. Nature. 617:386. PubMed
  145. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  146. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  147. Zhang R, et al. 2019. Cell Rep. 28:2647. PubMed
  148. Mancini M, et al. 2019. J Immunol. 202:1479. PubMed
  149. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  150. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  151. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  152. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  153. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  154. Dong L, et al. 2021. Cancer Cell. . PubMed
  155. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  156. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  157. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  158. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  159. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  160. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  161. Dupont C, et al. 2015. J Immunol. 195: 4369 - 4377. PubMed
  162. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  163. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  164. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  165. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  166. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  167. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  168. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  169. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  170. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  171. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  172. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  173. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  174. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  175. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  176. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  177. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  178. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  179. Ortiz-Bonilla CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  180. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
  181. Dupont C, et al. 2014. PLoS Pathog. 10:1004047. PubMed
  182. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  183. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  184. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  185. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  186. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  187. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  188. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  189. Chen YG, et al. 2020. Molecular Cell. 76(1):96-109. PubMed
  190. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  191. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  192. Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
  193. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  194. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  195. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  196. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  197. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  198. De Simone G, et al. 2021. Immunity. :. PubMed
  199. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  200. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  201. Blriot C, et al. 2021. Immunity. :. PubMed
  202. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  203. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  204. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  205. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  206. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  207. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  208. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  209. Quiding-Järbrink M, et al. 2010. PLoS One. 5:e15018. PubMed
  210. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  211. Cunha LD et al. 2018. Cell. 175(2):429-441 . PubMed
  212. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  213. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  214. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  215. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  216. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  217. Utz SG, et al. 2020. Cell. 181(3):557-573. PubMed
  218. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  219. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  220. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  221. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  222. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  223. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  224. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  225. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  226. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  227. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  228. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  229. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  230. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  231. Mogilenko DA et al. 2019. Cell. 177(5):1201-1216 . PubMed
  232. Braza MS et al. 2018. Immunity. 49(5):819-828 . PubMed
  233. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  234. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  235. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  236. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  237. Droho S, et al. 2020. J Vis Exp. . PubMed
  238. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  239. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  240. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  241. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  242. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  243. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  244. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  245. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  246. C Khouili S, et al. 2020. Cell Rep. 33:108468. PubMed
RRID
AB_493727 (BioLegend Cat. No. 107622)
AB_493726 (BioLegend Cat. No. 107621)

Antigen Details

Structure
MHC class II
Distribution

B cell and activated T cells, APCs of the H-2b,d,q,r bearing mice

Function
Antigen presentation
Ligand/Receptor
CD3/TCR, CD4
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, T cells, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
MHC Antigens
Antigen References

1. Watts C. 1997. Ann. Rev. Immunol. 15:821.
2. Pamer E, et al. 1998. Ann. Rev. Immunol. 16:323.

Gene ID
14961 View all products for this Gene ID 14969 View all products for this Gene ID
UniProt
View information about I-A/I-E on UniProt.org

Related FAQs

If an antibody clone has been previously successfully used in IBEX in one fluorescent format, will other antibody formats work as well?

It’s likely that other fluorophore conjugates to the same antibody clone will also be compatible with IBEX using the same sample fixation procedure. Ultimately a directly conjugated antibody’s utility in fluorescent imaging and IBEX may be specific to the sample and microscope being used in the experiment. Some antibody clone conjugates may perform better than others due to performance differences in non-specific binding, fluorophore brightness, and other biochemical properties unique to that conjugate.

Will antibodies my lab is already using for fluorescent or chromogenic IHC work in IBEX?

Fundamentally, IBEX as a technique that works much in the same way as single antibody panels or single marker IF/IHC. If you’re already successfully using an antibody clone on a sample of interest, it is likely that clone will have utility in IBEX. It is expected some optimization and testing of different antibody fluorophore conjugates will be required to find a suitable format; however, legacy microscopy techniques like chromogenic IHC on fixed or frozen tissue is an excellent place to start looking for useful antibodies.

Are other fluorophores compatible with IBEX?

Over 18 fluorescent formats have been screened for use in IBEX, however, it is likely that other fluorophores are able to be rapidly bleached in IBEX. If a fluorophore format is already suitable for your imaging platform it can be tested for compatibility in IBEX.

The same antibody works in one tissue type but not another. What is happening?

Differences in tissue properties may impact both the ability of an antibody to bind its target specifically and impact the ability of a specific fluorophore conjugate to overcome the background fluorescent signal in a given tissue. Secondary stains, as well as testing multiple fluorescent conjugates of the same clone, may help to troubleshoot challenging targets or tissues. Using a reference control tissue may also give confidence in the specificity of your staining.

How can I be sure the staining I’m seeing in my tissue is real?

In general, best practices for validating an antibody in traditional chromogenic or fluorescent IHC are applicable to IBEX. Please reference the Nature Methods review on antibody based multiplexed imaging for resources on validating antibodies for IBEX.

Other Formats

View All I-A/I-E Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse I-A/I-E (Maxpar® Ready) M5/114.15.2 FC,CyTOF®
Brilliant Violet 605™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 650™ anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 594 anti-mouse I-A/I-E M5/114.15.2 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 785™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 711™ anti-mouse I-A/I-E M5/114.15.2 FC
APC/Fire™ 750 anti-mouse I-A/I-E M5/114.15.2 FC
TotalSeq™-A0117 anti-mouse I-A/I-E M5/114.15.2 PG
Ultra-LEAF™ Purified anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,IP,Block
TotalSeq™-B0117 anti-mouse I-A/I-E M5/114.15.2 PG
TotalSeq™-C0117 anti-mouse I-A/I-E M5/114.15.2 PG
Spark Blue™ 550 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Fire™ 640 anti-mouse I-A/I-E M5/114.15.2 FC
FITC anti-mouse I-A/I-E M5/114.15.2 FC
Purified anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,IP,Block
PE/Cyanine5 anti-mouse I-A/I-E M5/114.15.2 FC
APC anti-mouse I-A/I-E M5/114.15.2 FC
PE anti-mouse I-A/I-E M5/114.15.2 FC
Biotin anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 488 anti-mouse I-A/I-E M5/114.15.2 FC,3D IHC
Alexa Fluor® 647 anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 700 anti-mouse I-A/I-E M5/114.15.2 FC,SB
Pacific Blue™ anti-mouse I-A/I-E M5/114.15.2 FC
PerCP/Cyanine5.5 anti-mouse I-A/I-E M5/114.15.2 FC
PerCP anti-mouse I-A/I-E M5/114.15.2 FC
APC/Cyanine7 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Cyanine7 anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 510™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 421™ anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,SB
Spark YG™ 581 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Fire™ 810 anti-mouse I-A/I-E M5/114.15.2 FC
Spark UV™ 387 anti-mouse I-A/I-E M5/114.15.2 FC
Spark Violet™ 538 anti-mouse I-A/I-E M5/114.15.2 FC
PerCP/Fire™ 806 anti-mouse I-A/I-E M5/114.15.2 FC
Spark Red™ 718 anti-mouse I-A/I-E M5/114.15.2 FC
APC/Fire™ 810 anti-mouse I-A/I-E M5/114.15.2 FC
Spark PLUS UV395™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 750™ anti-mouse I-A/I-E M5/114.15.2 FC
Spark YG™ 593 anti-mouse I-A/I-E (Flexi-Fluor™) Antibody M5/114.15.2 FC
Spark NIR™ 685 anti-mouse I-A/I-E (Flexi-Fluor™) Antibody M5/114.15.2 FC
StarBright UltraViolet 795 anti-mouse I-A/I-E M5/114.15.2 FC
Spark PLUS B574™ anti-mouse I-A/I-E Antibody M5/114.15.2 FC
Go To Top Version: 6    Revision Date: 04-21-2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account